Trials / Terminated
TerminatedNCT02488629
Study of SCB01A in Patient With Head and Neck Cancer
An Open-Label, Phase II Study to Evaluate SCB01A in Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Who Have Received Platinum-Based Treatment
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- SynCore Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of SCB01A in head and neck cancer.
Detailed description
The study is designed to evaluate the safety and efficacy of SCB01A in patients with recurrent or metastatic squamous cell carcinoma in head and neck.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCB01A | This study is a single arm, open-label, Phase II trial |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-07-02
- Last updated
- 2023-06-27
- Results posted
- 2023-06-27
Locations
5 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02488629. Inclusion in this directory is not an endorsement.